152 related articles for article (PubMed ID: 32048971)
1. Prospective Application of Aptamer-based Assays and Therapeutics in Bloodstream Infections.
Li W
Mini Rev Med Chem; 2020; 20(10):831-840. PubMed ID: 32048971
[TBL] [Abstract][Full Text] [Related]
2. Aptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease.
Li W; Lan X
Nucleic Acid Ther; 2015 Aug; 25(4):173-9. PubMed ID: 25993618
[TBL] [Abstract][Full Text] [Related]
3. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
[TBL] [Abstract][Full Text] [Related]
4. Selection, characterization, and application of DNA aptamers for detection of Mycobacterium tuberculosis secreted protein MPT64.
Sypabekova M; Bekmurzayeva A; Wang R; Li Y; Nogues C; Kanayeva D
Tuberculosis (Edinb); 2017 May; 104():70-78. PubMed ID: 28454652
[TBL] [Abstract][Full Text] [Related]
5. Aptamer chemistry.
Röthlisberger P; Hollenstein M
Adv Drug Deliv Rev; 2018 Sep; 134():3-21. PubMed ID: 29626546
[TBL] [Abstract][Full Text] [Related]
6. High Efficiency Binding Aptamers for a Wide Range of Bacterial Sepsis Agents.
Graziani AC; Stets MI; Lopes ALK; Schluga PHC; Marton S; Mendes IF; Andrade ASR; Krieger MA; Cardoso J
J Microbiol Biotechnol; 2017 Apr; 27(4):838-843. PubMed ID: 28119514
[TBL] [Abstract][Full Text] [Related]
7. A Combined ELONA-(RT)qPCR Approach for Characterizing DNA and RNA Aptamers Selected against PCBP-2.
Moreno M; Fernández-Algar M; Fernández-Chamorro J; Ramajo J; Martínez-Salas E; Briones C
Molecules; 2019 Mar; 24(7):. PubMed ID: 30925703
[TBL] [Abstract][Full Text] [Related]
8. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
9. Current approaches in SELEX: An update to aptamer selection technology.
Darmostuk M; Rimpelova S; Gbelcova H; Ruml T
Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1141-61. PubMed ID: 25708387
[TBL] [Abstract][Full Text] [Related]
10. Application of aptamers for targeted therapeutics.
Ray P; Viles KD; Soule EE; Woodruff RS
Arch Immunol Ther Exp (Warsz); 2013 Aug; 61(4):255-71. PubMed ID: 23563807
[TBL] [Abstract][Full Text] [Related]
11. Aptamers as Therapeutics.
Nimjee SM; White RR; Becker RC; Sullenger BA
Annu Rev Pharmacol Toxicol; 2017 Jan; 57():61-79. PubMed ID: 28061688
[TBL] [Abstract][Full Text] [Related]
12. A combinatorial systematic evolution of ligands by exponential enrichment method for selection of aptamer against protein targets.
Mondal B; Ramlal S; Lavu PS; Murali HS; Batra HV
Appl Microbiol Biotechnol; 2015 Nov; 99(22):9791-803. PubMed ID: 26293334
[TBL] [Abstract][Full Text] [Related]
13. Aptamers in hematological malignancies and their potential therapeutic implications.
Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
[TBL] [Abstract][Full Text] [Related]
14. Selection of aptamers against pathogenic bacteria and their diagnostics application.
Wang L; Wang R; Wei H; Li Y
World J Microbiol Biotechnol; 2018 Sep; 34(10):149. PubMed ID: 30220026
[TBL] [Abstract][Full Text] [Related]
15. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
Wu Z; Xue S; Yang Y
Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
[TBL] [Abstract][Full Text] [Related]
16. Generation of Specific Aptamers.
Liu S; Suzuki Y; Inui M
Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458
[TBL] [Abstract][Full Text] [Related]
17. Selection and Identification of Chloramphenicol-Specific DNA Aptamers by Mag-SELEX.
Duan Y; Gao Z; Wang L; Wang H; Zhang H; Li H
Appl Biochem Biotechnol; 2016 Dec; 180(8):1644-1656. PubMed ID: 27613616
[TBL] [Abstract][Full Text] [Related]
18. Trends in aptamer selection methods and applications.
Yüce M; Ullah N; Budak H
Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
[TBL] [Abstract][Full Text] [Related]
19. Selection and Identification of Novel Aptamers Specific for Clenbuterol Based on ssDNA Library Immobilized SELEX and Gold Nanoparticles Biosensor.
Liu X; Lu Q; Chen S; Wang F; Hou J; Xu Z; Meng C; Hu T; Hou Y
Molecules; 2018 Sep; 23(9):. PubMed ID: 30216975
[TBL] [Abstract][Full Text] [Related]
20. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
Ouellet E; Lagally ET; Cheung KC; Haynes CA
Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
